MOREPENLABNSEMorepen Laboratories Limited· PharmaceuticalsLowNeutral
Announced Tue, 10 Feb · 16:28 IST

Please find attached the Monitoring Agency Report for the quarter ended December 31, 2025

MOREPENLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Morepen Laboratories has submitted its Monitoring Agency Report for the quarter ending December 31, 2025, as required by SEBI regulations. A monitoring agency is appointed by companies that raise funds exceeding ₹100 crore through public or preferential issues, and it tracks how the company uses the money it raised. The report covers utilization of issue proceeds during the October-December 2025 quarter. Specific details on funds raised, amount used, and any deviations from the stated purpose are not included in the headline and would be in the attached report.

Likely market impact

This is a routine regulatory compliance filing and is unlikely to have a direct impact on the stock price, though investors should review the report to confirm the company is using the raised funds as originally promised.